Literature DB >> 12042422

Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism.

Suyeon Kim1, Jay Whelan, Kate Claycombe, David B Reath, Naima Moustaid-Moussa.   

Abstract

We previously reported that angiotensin II (Ang II) increases adipocyte fatty acid synthesis and triglyceride content. Triglyceride stores or adiposity correlate positively with the amount of circulating leptin. Ang II was proposed to increase adipocyte differentiation and growth by promoting prostaglandin (PG) production. The purpose of this study was to determine whether Ang II increases leptin secretion via a PG-dependent mechanism. Physiologic doses of Ang II significantly increased leptin secretion by 3T3-L1 adipocytes and human adipocytes. Elevation of PG secretions was elicited at physiologic concentrations of Ang II (P < 0.05). Secretions of 6-keto PGF(1alpha), a stable derivative of PGI(2), and PGE(2) were induced by physiologic concentrations of Ang II in a time-responsive fashion (P < 0.05). Inhibition of PG synthesis by indomethacin and aspirin significantly suppressed basal as well as Ang II-induced PG levels, but did not significantly affect basal and Ang II-induced leptin secretion. In conclusion, although Ang II stimulates both leptin and PG secretion by adipocytes, regulation of leptin secretion by Ang II in adipocytes is not mediated by a PG-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042422     DOI: 10.1093/jn/132.6.1135

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  20 in total

1.  Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure.

Authors:  Helge Müller-Fielitz; Antonie Markert; Christian Wittmershaus; Friedrich Pahlke; Olaf Jöhren; Walter Raasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-03       Impact factor: 3.000

2.  Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.

Authors:  Stefan Zorad; Jing-tao Dou; Julius Benicky; Daniel Hutanu; Katarina Tybitanclova; Jin Zhou; Juan M Saavedra
Journal:  Eur J Pharmacol       Date:  2006-09-09       Impact factor: 4.432

Review 3.  (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights.

Authors:  Nishan S Kalupahana; Kate J Claycombe; Naima Moustaid-Moussa
Journal:  Adv Nutr       Date:  2011-06-28       Impact factor: 8.701

4.  Leptin impairs cardiovagal baroreflex function at the level of the solitary tract nucleus.

Authors:  Amy C Arnold; Hossam A Shaltout; Patricia E Gallagher; Debra I Diz
Journal:  Hypertension       Date:  2009-09-21       Impact factor: 10.190

Review 5.  Brain renin-angiotensin system in the nexus of hypertension and aging.

Authors:  Amy C Arnold; Patricia E Gallagher; Debra I Diz
Journal:  Hypertens Res       Date:  2012-10-18       Impact factor: 3.872

6.  Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity.

Authors:  Paula Stucchi; Victoria Cano; Mariano Ruiz-Gayo; María S Fernández-Alfonso
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

7.  Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.

Authors:  Helge Müller-Fielitz; Nils Hübel; Martin Mildner; Florian M Vogt; Jörg Barkhausen; Walter Raasch
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

8.  Changes in Central Aortic Pressure, Endothelial Function and Biomarkers in Hypertensive African-Americans with the Cardiometabolic Syndrome: Comparison of Amlodipine/Olmesartan versus Hydrochlorothiazide/Losartan.

Authors:  Bobby V Khan; Nadya Merchant; Syed T Rahman; Mushtaq Ahmad; Janice M Parrott; Kanwal Umar; Julie Johnson; Keith C Ferdinand
Journal:  Cardiorenal Med       Date:  2013-10-02       Impact factor: 2.041

9.  Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible role in amelioration of insulin resistance and hepatic steatosis.

Authors:  Junji Yokozawa; Takashi Sasaki; Kumiko Ohwada; Yayoi Sasaki; Jun-Itsu Ito; Takafumi Saito; Sumio Kawata
Journal:  J Gastroenterol       Date:  2009-04-14       Impact factor: 7.527

10.  n3 and n6 polyunsaturated fatty acids differentially modulate prostaglandin E secretion but not markers of lipogenesis in adipocytes.

Authors:  Patrick Wortman; Yuko Miyazaki; Nishan S Kalupahana; Suyeon Kim; Melissa Hansen-Petrik; Arnold M Saxton; Kate J Claycombe; Brynn H Voy; Jay Whelan; Naima Moustaid-Moussa
Journal:  Nutr Metab (Lond)       Date:  2009-01-21       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.